title: Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways.
authors.forename: Hitendra S
authors.initials: HS
authors.lastname: Chand
authors.forename: Mark
authors.initials: M
authors.lastname: Schuyler
authors.forename: Nancy
authors.initials: N
authors.lastname: Joste
authors.forename: Charlene
authors.initials: C
authors.lastname: Hensler
authors.forename: Yohannes
authors.initials: Y
authors.lastname: Tesfaigzi
authors.forename: Barbara
authors.initials: B
authors.lastname: Masten
authors.forename: Ron
authors.initials: R
authors.lastname: Schrader
authors.forename: Mary F
authors.initials: MF
authors.lastname: Lipscomb
mesh_terms: D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D001980:Bronchi / Q000166:cytology / Q000276:immunology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D022423:Myeloid Cells / Q000166:cytology / Q000276:immunology; D000069444:Omalizumab; D016896:Treatment Outcome
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C026408:anti-IgE antibodies; D000069444:Omalizumab